We determined the role of Fhit gene expression in MHC-I expression, oncogenicity, and immunogenicity in B9 and B11 tumor cell lines, both of which are MHC-I negative and recover expression of H-2 class I molecules K, D, and L after in vitro treatment with IFN-γ (Figure S1). The gene discussed is IFNG; the disease is neoplasm.